Stock Analysis on Net

UnitedHealth Group Inc. (NYSE:UNH)

Price to FCFE (P/FCFE)

Microsoft Excel

Free Cash Flow to Equity (FCFE)

UnitedHealth Group Inc., FCFE calculation

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Net earnings attributable to UnitedHealth Group common shareholders 14,405 22,381 20,120 17,285 15,403
Earnings attributable to noncontrolling interests 837 763 519 447 366
Net noncash charges 9,770 4,281 3,321 3,089 3,510
Net change in other operating items, net of effects from acquisitions and dispositions (808) 1,643 2,246 1,522 2,895
Cash flows from operating activities 24,204 29,068 26,206 22,343 22,174
Purchases of property, equipment and capitalized software (3,499) (3,386) (2,802) (2,454) (2,051)
Repayments of long-term debt (3,000) (2,125) (3,015) (3,150) (3,150)
Proceeds from (repayments of) short-term borrowings, net (151) 11 732 (1,302) 872
Proceeds from issuance of long-term debt 17,811 6,394 14,819 6,933 4,864
Free cash flow to equity (FCFE) 35,365 29,962 35,940 22,370 22,709

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Item Description The company
FCFE Free cash flow to equity is the cash flow available to UnitedHealth Group Inc. equity holders after all operating expenses, interest, and principal payments have been paid and necessary investments in working and fixed capital have been made. UnitedHealth Group Inc. FCFE decreased from 2022 to 2023 but then increased from 2023 to 2024 not reaching 2022 level.

Price to FCFE Ratio, Current

UnitedHealth Group Inc., current P/FCFE calculation, comparison to benchmarks

Microsoft Excel
No. shares of common stock outstanding 907,140,441
Selected Financial Data (US$)
Free cash flow to equity (FCFE) (in millions) 35,365
FCFE per share 38.99
Current share price (P) 321.58
Valuation Ratio
P/FCFE 8.25
Benchmarks
P/FCFE, Competitors1
Abbott Laboratories 40.46
CVS Health Corp. 7.08
Elevance Health Inc. 8.67
Intuitive Surgical Inc. 153.16
Medtronic PLC 17.66
P/FCFE, Sector
Health Care Equipment & Services 14.26
P/FCFE, Industry
Health Care 16.77

Based on: 10-K (reporting date: 2024-12-31).

1 Click competitor name to see calculations.

If the company P/FCFE is lower then the P/FCFE of benchmark then company is relatively undervalued.
Otherwise, if the company P/FCFE is higher then the P/FCFE of benchmark then company is relatively overvalued.


Price to FCFE Ratio, Historical

UnitedHealth Group Inc., historical P/FCFE calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
No. shares of common stock outstanding1 914,712,333 921,934,109 932,846,602 940,899,146 945,319,404
Selected Financial Data (US$)
Free cash flow to equity (FCFE) (in millions)2 35,365 29,962 35,940 22,370 22,709
FCFE per share3 38.66 32.50 38.53 23.78 24.02
Share price1, 4 468.56 498.28 484.33 478.23 334.65
Valuation Ratio
P/FCFE5 12.12 15.33 12.57 20.11 13.93
Benchmarks
P/FCFE, Competitors6
Abbott Laboratories 40.25 76.56 26.11 24.52 38.42
CVS Health Corp. 7.00 5.22 12.36 21.23 11.93
Elevance Health Inc. 8.26 16.04 14.26 11.07 7.75
Intuitive Surgical Inc. 156.44 177.77 89.67 58.39 81.15
Medtronic PLC 16.39 29.20 19.71 38.91 23.06
P/FCFE, Sector
Health Care Equipment & Services 16.05 17.79 15.91 22.03 17.62
P/FCFE, Industry
Health Care 18.69 17.15 18.11 18.05 17.25

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 Data adjusted for splits and stock dividends.

2 See details »

3 2024 Calculation
FCFE per share = FCFE ÷ No. shares of common stock outstanding
= 35,365,000,000 ÷ 914,712,333 = 38.66

4 Closing price as at the filing date of UnitedHealth Group Inc. Annual Report.

5 2024 Calculation
P/FCFE = Share price ÷ FCFE per share
= 468.56 ÷ 38.66 = 12.12

6 Click competitor name to see calculations.

Valuation ratio Description The company
P/FCFE Price to free cash flow to equity is cash valuation indicator of stockholders’ equity. UnitedHealth Group Inc. P/FCFE ratio increased from 2022 to 2023 but then decreased significantly from 2023 to 2024.